financetom
Business
financetom
/
Business
/
Blackstone-led consortium eyes snacks business of India's Haldiram's, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blackstone-led consortium eyes snacks business of India's Haldiram's, sources say
May 13, 2024 10:07 PM

MUMBAI, May 14 (Reuters) - A consortium including

Blackstone, Singapore state fund GIC and Abu Dhabi

Investment Authority (ADIA) is in talks with India's Haldiram's

for a majority stake in its snacks business at a valuation of up

to $8.5 billion, two sources with direct knowledge said.

Haldiram's, a household name in India, has more than 150

restaurants selling local food, sweets and western cuisine. It

also has a popular snacks business for which the deal talks are

currently ongoing, said the sources, who declined to be named as

the discussions are private.

The consortium, led by Blackstone, has submitted a

non-binding bid for a 75% stake and the talks are in early

stages, the sources said, adding that the final percentage and

valuation has not yet been decided.

GIC and ADIA - both investors in Blackstone's funds - are

part of the non-binding bid, the sources added. India's Economic

Times newspaper first reported the deal talks.

Haldiram's CEO Krishan Chutani, ADIA and Blackstone declined

to comment while GIC did not immediately respond.

Last year, Reuters reported India's Tata Group was in talks

with Haldiram's to acquire a majority stake in the entire snacks

and restaurants business. Haldiram's at the time was seeking a

valuation of $10 billion.

Those talks have ended and no Tata deal is in the works, a

third source with direct knowledge said on Tuesday.

(Reporting by M. Sriram; Editing by Lincoln Feast.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioCryst Pharmaceuticals' Study of Orladeyo Finds Hospitalization Reduction for Hereditary Angioedema Patients
BioCryst Pharmaceuticals' Study of Orladeyo Finds Hospitalization Reduction for Hereditary Angioedema Patients
Oct 16, 2024
08:25 AM EDT, 10/14/2024 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Monday a study of berotralstat, which it markets under the brand name of Orladeyo, showed a significant reduction in hospitalizations, emergency room visits, and use of on-demand therapies for patients with hereditary angioedema in the US. The company said that the study of berotralstat will be presented...
Boeing hones $15 billion financing plan to weather crises, sources say
Boeing hones $15 billion financing plan to weather crises, sources say
Oct 16, 2024
By Shankar Ramakrishnan, Echo Wang and Tim Hepher (Reuters) -Boeing is closing in on a plan to raise around $15 billion with common shares and a mandatory convertible bond as the jetmaker bolsters finances worsened by a crippling strike, but the timing remains unclear, four sources familiar with the matter told Reuters. The company said on Tuesday in regulatory filings...
Minerals Technologies Lifts Quarterly Dividend, Sets $200 Million Share Buyback Program
Minerals Technologies Lifts Quarterly Dividend, Sets $200 Million Share Buyback Program
Oct 16, 2024
05:48 PM EDT, 10/16/2024 (MT Newswires) -- Minerals Technologies ( MTX ) said Wednesday it increased its regular quarterly dividend by 10% to $0.11 per share, payable on Dec. 5 to stockholders of record on Oct. 31. The company also said it has been authorized by its board to buy back $200 million of its shares. ...
BRIEF-Uber Explored Possible Bid For Expedia In 'Super App' Growth Push -  FT
BRIEF-Uber Explored Possible Bid For Expedia In 'Super App' Growth Push - FT
Oct 16, 2024
Oct 16 (Reuters) - * UBER EXPLORED POSSIBLE BID FOR EXPEDIA IN 'SUPER APP' GROWTH PUSH - FT Source text for Eikon: https://tinyurl.com/22k9lwp7 Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved